Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer

As survival in breast cancer patients from newer therapies increases, concerns for chemotherapy-induced cardiotoxicity (CIC) have offset some of these benefits, manifesting as a decline in left ventricular ejection fraction (LVEF). Patients receiving anthracycline-based chemotherapy followed by tras...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnarao, Krithika, Bruno, Katelyn A., Di Florio, Damian N., Edenfield, Brandy H., Whelan, Emily R., Macomb, Logan P., McGuire, Molly M., Hill, Anneliese R., Ray, Jordan C., Cornell, Lauren F., Tan, Winston, Geiger, Xochiquetzal J., Salomon, Gary R., Douglass, Erika J., Fairweather, DeLisa, Yamani, Mohamad H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224558/
https://www.ncbi.nlm.nih.gov/pubmed/35743613
http://dx.doi.org/10.3390/jcm11123547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224558/
https://www.ncbi.nlm.nih.gov/pubmed/35743613
http://dx.doi.org/10.3390/jcm11123547

Ejemplares similares